Medfirst Healthcare ServicesROCO:4175 +0.19%71 EBITDA Margin % is 13.00% as of Dec. 2025, which is 17% above its 10-year median of 11.12. GuruFocus rates ROCO:4175 with a GF Score™ of 71/100 and a GF Value™ of NT$74.49 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Medfirst Healthcare Services ranks better than 57.36% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medfirst Healthcare Services EBITDA Margin % Related Terms
Medfirst Healthcare Services EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Medfirst Healthcare Services's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medfirst Healthcare Services EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medfirst Healthcare Services's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medfirst Healthcare Services's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medfirst Healthcare Services (ROCO:4175) has a EBITDA Margin % of 13.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medfirst Healthcare Services and its competitors. This is 17% above median its historical median of 11.12. Over the past decade, Medfirst Healthcare Services' EBITDA Margin % has ranged from 4.67 to 13.04. According to the industry distribution chart, Medfirst Healthcare Services ranks #284 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 42.6%.
Is Medfirst Healthcare Services' EBITDA Margin % too high?
Medfirst Healthcare Services' current EBITDA Margin % of 13.00% is 17% above median its 10-year median of 11.12. Over the past 10 years, this metric has ranged from a low of 4.67 to a high of 13.04. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Medfirst Healthcare Services' value of 13.00% is 27.3% above this industry median. Based on the distribution chart, Medfirst Healthcare Services ranks #284 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medfirst Healthcare Services has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medfirst Healthcare Services' EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Medfirst Healthcare Services ranks #284 out of 666 companies for EBITDA Margin %. This puts Medfirst Healthcare Services in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Medfirst Healthcare Services' value of 13.00% is 27.3% above this benchmark. Historically, Medfirst Healthcare Services' own EBITDA Margin % has ranged from 4.67 to 13.04 over the past decade. While the company's 10-year median is 11.12 vs. the industry median of 10.21, Medfirst Healthcare Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medfirst Healthcare Services's current EBITDA Margin % of 13.00% is 27.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medfirst Healthcare Services and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medfirst Healthcare Services's current EBITDA Margin % is 13.00%, which is 17% above median its own 10-year median of 11.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medfirst Healthcare Services stock overvalued right now?
Based on GuruFocus' analysis, Medfirst Healthcare Services (ROCO:4175) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$74.49, compared to a current price of NT$53.20 — trading 28.6% below its estimated fair value. The current EBITDA Margin % is 13.00%, which is 17% above median its 10-year median of 11.12 and 27.3% above the Healthcare Providers & Services industry median of 10.21. Medfirst Healthcare Services' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medfirst Healthcare Services (ROCO:4175), the current EBITDA Margin % is 13.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medfirst Healthcare Services (ROCO:4175) Overvalued in 2026?
Based on GuruFocus' analysis, Medfirst Healthcare Services stock appears to be undervalued.
The current stock price of NT$53.20 is trading 28.6% below its estimated GF Value™ of NT$74.49.
GuruFocus considers Medfirst Healthcare Services to be Modestly Undervalued.
Key valuation signals for ROCO:4175:
EBITDA Margin %: 13.00% (17% above median its 10-year median of 11.12)
GF Value™: NT$74.49 vs. price of NT$53.20 (28.6% below fair value)
Industry Position: 27.3% above the Healthcare Providers & Services median (#284 of 666)
No single metric tells the full story. See the ROCO:4175 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medfirst Healthcare Services Inc is mainly engaged in the sale of medical supplies and the management of shopping malls. The company's geographical segment includes Mainland China and Taiwan. It generates maximum revenue from Taiwan. The company derives a majority of its revenue from medical care products followed by health care.
71GF Score
Get the complete analysis for ROCO:4175
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4175 has been successfully added to your 
